Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1·FGFR2c·Heparin Ternary Complexes*

The related glycosaminoglycans heparin and heparan sulfate are essential for the activity of the fibroblast growth factor (FGF) family as they form an integral part of the signaling complex at the cell surface. Using size-exclusion chromatography we have studied the capacities of a variety of heparin oligosaccharides to bind FGF1 and FGFR2c both separately and together in ternary complexes. In the absence of heparin, FGF1 had no detectable affinity for FGFR2c. However, 2:2:1 complexes formed spontaneously in solution between FGF1, FGFR2c, and heparin octasaccharide (dp8). The dp8 sample was the shortest chain length that bound FGFR2c, that dimerized FGF1, and that promoted a strong mitogenic response to FGF1 through FGFR2c. Heparin hexasaccharide and various selectively desulfated heparin dp12s failed to bind FGFR2c and could only interact with FGF1 monomerically. These saccharides formed 1:1:1 complexes with FGF1 and FGFR2c, which had no tendency to self-associate, suggesting that binding of two FGF1 molecules to the same saccharide chain is a prerequisite for subsequent FGFR2c dimerization. We found that FGF1 dimerization upon heparin was favored over monomeric interactions even when a large excess of saccharide was present. A cooperative mechanism of FGF1 dimerization could explain how 2:2:1 signaling complexes form at the cell surface, an environment rich in heparan sulfate.

[1]  J. Turnbull,et al.  Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. , 2004, Glycobiology.

[2]  M. Lyon,et al.  A New Model for the Domain Structure of Heparan Sulfate Based on the Novel Specificity of K5 Lyase* , 2004, Journal of Biological Chemistry.

[3]  M. Mohammadi,et al.  Structure‐based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb , 2003, FEBS letters.

[4]  V. Sasisekharan,et al.  Structural specificity of heparin binding in the fibroblast growth factor family of proteins , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Heikinheimo,et al.  Expression and glycosylation studies of human FGF receptor 4. , 2001, Protein expression and purification.

[6]  T. Blundell,et al.  Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex. , 2004, Journal of molecular biology.

[7]  X. Coumoul,et al.  Roles of FGF receptors in mammalian development and congenital diseases. , 2003, Birth defects research. Part C, Embryo today : reviews.

[8]  D. Svergun,et al.  CRYSOL : a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates , 1995 .

[9]  L. Pellegrini,et al.  Role of heparan sulfate in fibroblast growth factor signalling: a structural view. , 2001, Current opinion in structural biology.

[10]  Robert J Linhardt,et al.  Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Y. Yarden,et al.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. , 1992, The EMBO journal.

[12]  D. Ornitz,et al.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[14]  D. Ron,et al.  Differential Effects of Heparin Saccharides on the Formation of Specific Fibroblast Growth Factor (FGF) and FGF Receptor Complexes* , 2002, The Journal of Biological Chemistry.

[15]  L. Kjellén Glucosaminyl N-deacetylase/N-sulphotransferases in heparan sulphate biosynthesis and biology. , 2003, Biochemical Society transactions.

[16]  B. L. Allen,et al.  Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly , 2003, The Journal of cell biology.

[17]  M. Salmivirta,et al.  Binding of Heparin/Heparan Sulfate to Fibroblast Growth Factor Receptor 4* , 2001, The Journal of Biological Chemistry.

[18]  M. Mohammadi,et al.  Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Isacchi,et al.  Characterization of a biologically active extracellular domain of fibroblast growth factor receptor 1 expressed in Escherichia coli. , 1992, European journal of biochemistry.

[20]  R. Pettersson,et al.  Characterization of fibroblast growth factor 1 binding heparan sulfate domain. , 1999, Glycobiology.

[21]  J. Turnbull,et al.  Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure. , 1991, The Biochemical journal.

[22]  J. Turnbull,et al.  Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity* , 1998, The Journal of Biological Chemistry.

[23]  J G Flanagan,et al.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.

[24]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[25]  A. Halfpenny,et al.  The structure of human acidic fibroblast growth factor and its interaction with heparin. , 1991, Archives of biochemistry and biophysics.

[26]  J. Xu,et al.  An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.

[27]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[28]  D. Rees,et al.  Three-dimensional structures of acidic and basic fibroblast growth factors. , 1993, Science.

[29]  M. Jeffers,et al.  Fibroblast growth factors in cancer: therapeutic possibilities , 2002, Expert opinion on therapeutic targets.

[30]  Joseph Schlessinger,et al.  Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.

[31]  Zhengliang L. Wu,et al.  The Involvement of Heparan Sulfate (HS) in FGF1/HS/FGFR1 Signaling Complex* , 2003, The Journal of Biological Chemistry.

[32]  Robert J. Linhardt,et al.  Analysis of Mutations in Fibroblast Growth Factor (FGF) and a Pathogenic Mutation in FGF Receptor (FGFR) Provides Direct Evidence for the Symmetric Two-End Model for FGFR Dimerization , 2005, Molecular and Cellular Biology.

[33]  D. Givol,et al.  Complexity of FGF receptors: genetic basis for structural diversity and functional specificity , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Wayne A. Hendrickson,et al.  Structure of a heparin-linked biologically active dimer of fibroblast growth factor , 1998, Nature.

[35]  Robert J Linhardt,et al.  Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. , 2004, Biochemistry.

[36]  B. Casu,et al.  Structure and biological interactions of heparin and heparan sulfate. , 2001, Advances in carbohydrate chemistry and biochemistry.

[37]  E. Gherardi,et al.  The Interactions of Hepatocyte Growth Factor/Scatter Factor and Its NK1 and NK2 Variants with Glycosaminoglycans Using a Modified Gel Mobility Shift Assay , 2004, Journal of Biological Chemistry.

[38]  J. Turnbull,et al.  Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate , 2002, The Journal of Biological Chemistry.

[39]  M. Forster,et al.  Conformation and dynamics of heparin and heparan sulfate. , 2000, Glycobiology.

[40]  M. Maccarana,et al.  S5.13 Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor , 1993, Glycoconjugate Journal.

[41]  G. M. Fox,et al.  Binding of heparin to basic fibroblast growth factor induces a conformational change. , 1992, Archives of biochemistry and biophysics.

[42]  D. Rabenstein Heparin and heparan sulfate: structure and function. , 2002, Natural product reports.

[43]  M. Humphries,et al.  Elucidation of the Structural Features of Heparan Sulfate Important for Interaction with the Hep-2 Domain of Fibronectin* , 2000, The Journal of Biological Chemistry.

[44]  C. Brown,et al.  Determination of X-chromosome inactivation status using X-linked expressed polymorphisms identified by database searching. , 2000, Genomics.